Superior Gr of Cos (NASDAQ:SGC) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call.

This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/.

Access the full call at https://event.choruscall.com/mediaframe/webcast.html?webcastid=CzhSmoEB

Summary

Superior Gr of Cos reported a 3% year-over-year increase in consolidated revenue for Q2 2026, with EBITDA rising 27% to $7.7 million and adjusted diluted EPS doubling from the previous year to $0.21.

Branded Products segment saw a 6% revenue increase due to higher volumes with existing customers, leading to a 25% EBITDA growth and improved gross margins.

Healthcare Apparel segment experienced a 4% revenue decline and a 260 basis point drop in gross margin due to a strategic inventory write-down, but management expects margin improvements in 2027.

Contact Centers reported a 4% revenue decline year-over-year but showed sequential improvement, driven by increased agent numbers and a strong pipeline of new business.

Strategic focus includes investments in technology and sales talent, with a strong pipeline and customer relationships expected to drive future growth.

Full-year guidance remains unchanged with expected net sales of $572 million to $585 million and adjusted EPS of $0.54 to $0.66, indicating a back-half weighted growth.

Management highlighted ongoing efforts to improve SG&A efficiency and leverage technology for operational improvements, particularly in the Contact Centers segment.

The company is actively seeking acquisition opportunities, particularly in areas that complement existing capabilities, but no immediate acquisitions outside of potential Contact Center expansion are anticipated.

Full Transcript

OPERATOR (Operator)

Good morning and welcome to the Superior Gr of Cos second quarter 2026 conference call. With us today are Michael Benstock, Chief Executive Officer, and Mike Koempel, President and Chief Financial Officer. In addition, Jake Himelstein, President of the Company's Branded Products segment, will join today's Q and A session. As a reminder, this conference call is being recorded. This call may contain forward-looking statements regarding the Company's plans, initiatives and strategies and the anticipated financial performance of the Company, including but not limited to sales and profitability.

Such statements are based upon management's current expectations, projections, estimates and assumptions. Words such as expect, believe, anticipate, think, outlook, hope and variations of such words and similar expressions identify such forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements. Such risks and uncertainties are further disclosed in the Company's periodic filings with the Securities and Exchange Commission, including but not limited to the Company's most recent Annual Report on Form 10-K and the quarterly reports on Form 10-Q. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The Company does not undertake to update the forward-looking statements except as required by law. And now I'll turn the call over to Michael Benstock.

Michael Benstock, CEO

Thank you, operator, and thanks everyone for joining us. We are proud to have delivered a strong quarter with consolidated revenue up 3% year over year, a 160 basis point improvement, EBITDA up 27% to $7.7 million and adjusted diluted EPS of $0.21, more than doubling the second quarter of 2025 excluding the non-cash trade name impairment that Mike will discuss, and reflects the progress we're making on mix, margin and earnings power. Our results highlight the benefit of our diversified business as we continue to navigate a choppy demand environment.

Our outlook remains favorable given our long-standing and solid customer relationships, the strength of their brands and our ability to support them with advanced technology, a flexible supply chain and stellar service. Turning to our segments, I'll start with Branded Products, our largest business. Revenue grew 6% year over year driven primarily by higher volumes with existing customers. We drove gross margin expansion along with SG&A improvement as a percent of sales.

Taken together, this led to a 25% increase in Branded Products EBITDA. As we look ahead, we believe our growing backlog and ongoing investments in sales, talent, marketing and technology will drive continued long-term growth. Our Healthcare Apparel revenue declined 4% and gross margin decreased by 260 basis points largely due to a non-cash inventory write-down tied to our recent strategic decision to accelerate the shift to a more focused product offering.

While we were able to reduce SG&A, SG&A as a percent of sales increased slightly on the lower revenue base and segment EBITDA declined by $1 million year over year. The quarter was undeniably challenging, but we view the shorter-term margin pressure and the transition under new leadership as necessary steps towards stronger, more sustainable margins and a more efficient use of working capital over time. Finally, in Contact Centers, as expected, revenue was down 4% year over year but improved sequentially for the second consecutive quarter.

The year-over-year decline reflects client attrition in 2025, whereas the more recent sequential improvement is driven by a net increase in agents year to date and stronger conversion from our significantly larger pipeline of new business than we had a year ago. Gross margin was lower due to higher human capital costs as we prepare for stronger growth ahead, which was more than offset by improved SG&A, which led to stronger EBITDA for the quarter.

To sum it up, we had a strong quarter and we see clear opportunities ahead for both growth and margin expansion. Our solid balance sheet and growing operating cash flow give us the flexibility to invest strategically across each of our segments. I'll now hand it over to Mike to walk through the financial details before we open the call up for questions.

Mike Koempel, President and CFO

Thank you, Michael, and welcome again everyone to the call. Second quarter consolidated revenue was $148 million, resulting in a 3% year over year increase for the second straight quarter. The revenue increase was driven by Branded Products, which increased 6% to $98 million from volume increases with existing customers. Revenue for Healthcare Apparel was $27 million, down 4% compared to the prior year due to tariff refunds. And lastly, revenue from our Contact Center segment was $23 million, also off 4% but sequentially improved from the first quarter's 8% year over year decline.

Our second quarter gross margin of 38% was down 40 basis points compared to the year-ago quarter. Branded Products drove gross margin of 36.5%, up nearly a full percentage point from the year-ago quarter, driven by customer mix. The Healthcare Apparel gross margin was 32.9% due to a $2.6 million incremental non-cash inventory write-down, partially offset by a $1.8 million net tariff refund benefit. The Contact Centers gross margin for the second quarter of 50.9% was down 170 basis points.

As Michael previously described, second quarter SG&A as a percent of sales of 34.7% improved 160 basis points year over year, driven by expense leverage in Branded Products on a 6% sales increase and an improvement in credit loss expense in the Branded Products and Contact Centers segments. Putting this all together, our second quarter EBITDA of $7.7 million improved from $6.1 million in the year-ago period. Moving further down the income statement, our net interest expense of $981,000 improved from $1.25 million in the second quarter of 2025 due to a lower weighted average interest rate and a decrease in average debt outstanding.

In terms of bottom line performance, second quarter net income was $1.2 million, or $0.08 per diluted share. In the second quarter of 2026 the company recognized a pre-tax non-cash impairment charge related to trade names in the Healthcare Apparel segment of $2.6 million, or $2 million net of tax, translating to $0.13 per diluted share. The charge does not affect the Company's cash position or cash flow from operating activities. On an adjusted basis, which excludes the impairment charge, second quarter net income was $3.1 million, or $0.21 per diluted share, up significantly from net income of $1.6 million, or $0.10 per diluted share, for the year-ago quarter. Turning to our balance sheet, we ended the second quarter with $23 million of cash and equivalents after generating first half operating cash flow of $18 million, and we remain well positioned to strategically invest in growth opportunities while returning capital to shareholders through both our attractive dividend yield and opportunistic share repurchases. Specifically, we paid $2.2 million in dividends during the second quarter and we have approximately $9 million available under our share repurchase authorization.

Turning to our full year outlook, we continue to expect 2026 net sales of $572 million to $585 million and look for adjusted diluted EPS of $0.54 to $0.66, well above the prior year's diluted EPS of $0.46. Once again, our guidance reflects a back-half weighted cadence again this year, both top and bottom line. And now, operator, if you could please open the lines. Michael, Jake and I would be happy to take questions.

OPERATOR (Operator)

We will now begin the question and answer session. To ask a question, you may press star then one on your touchtone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw the question, please press star then two at this time. We will pause momentarily to assemble our roster. Our first question comes from Michael Kopinski with Noble Capital Markets.

Please go ahead.

Michael Kopinski, Analyst at Noble Capital Markets

Thank you and good morning everyone. I was wondering if you can just maybe talk a little bit about Chris Heinz' operational changes in the Healthcare Apparel segment and when should those initiatives really start to begin producing some measurable revenue growth and maybe margin improvement? I was just wondering if you could just kind of outline for us and maybe give us some color on some of the changes that he's making there.

Mike Koempel, President and CFO

Hi Michael, this is Mike. Thanks for joining the call. Chris, obviously being just about three or four months into the business, but obviously spent a lot of time just getting integrated into the business and understanding the specific operations of the business. I'd say where he spent a lot of his time up to this point is really in the product and assortment part of the business. So from an operating perspective, a lot around how we're looking at collections, the merchandising, the sourcing associated with that, and the reason why that is, as you know, that's the long lead time in the business.

So it's important to get to that first because given the long lead time, it takes time to have the impact on the business. So he's really started with the product and beginning to formulate what he thinks is the appropriate assortment architecture going forward, which, as we said in our prepared remarks, is getting to what I would call a more focused assortment — so going, so to speak, narrower and deeper. So that's where he's really spent his time.

You can see in the quarter there's some margin pressure associated with beginning to make that assortment transition. We would expect some shorter-term margin pressure to continue through the balance of this year — not to the extent that you're seeing in the second quarter — but I would anticipate still some margin pressure on a year-over-year basis and then begin to see improvements in 2027.

Michael Kopinski, Analyst at Noble Capital Markets

Gotcha. Thanks for that color. On the Contact Centers, you know, the EBITDA was up strongly. Can you kind of just give us a little bit more color on the margin improvement and what, you know, maybe additional efficiencies remain available there? And then also it seems like you're quite positive about the new business pipeline. You know, are those just recent client wins and the attrition's coming down? When do you expect maybe the segment to return to year-over-year revenue growth?

Is that, are you still kind of thinking that it's going to be in like the second half, maybe the third quarter?

Mike Koempel, President and CFO

Yeah. On the Contact Center side, the margin improvement in the second quarter continues to reflect improved SG&A. That's in part because last year we're lapping a credit loss reserve associated with a former customer last year. But it also continues to reflect the cost reductions and efficiencies that the business put in place. So what's really good is we continue to see that we're essentially sustaining those reductions in SG&A, which is driving an improvement in the EBITDA margin.

What we said at the beginning of the year, and we're seeing it through the results, is that we expect the Contact Center segment to sequentially improve in the top line, which will drive EBITDA margin improvement as we go quarter to quarter, again because of the SG&A leverage that we're getting. What you see in the second quarter Gross margins were down a little bit. There were some initial investments we're making to onboard new customers this quarter that won't repeat. So we'd expect the gross margin rate to improve in the back half. So I think between continued sequential improvement in sales, continuing to manage expenses, and gross margins rebounding, we expect the EBITDA margin of that business to continue to improve as we go into the back half. The sales growth is really, Michael, a combination of some nice expansion with existing customers — we've added some seats with existing customers — and we have an increase in the conversion of new customers in the first six months this year as compared to the first six months last year. The decision-making is still slow, but despite that, we were able to convert more customers this year. Our expectation is that will continue through the balance of the year, which again would drive incremental sales growth into Q3 and then in Q4.

Michael Kopinski, Analyst at Noble Capital Markets

Great. If I could slip one more in on Branded Products. Obviously you had growth now for three consecutive quarters. I was just wondering if you can talk a little bit about how you see the growth for the rest of the year. And then on the margins — they were structurally higher; it looked like 11.4% margins, well above what we had in 2024 — I was just wondering if you could talk a little bit about what's driving the margin improvement there. And then if you can just talk a little bit about the customer mix and how things are shaping up for the balance of the year.

Jake Himelstein (President of Branded Products segment)

Hey, Michael, this is Jake Himelstein. I'll try to unpack those questions, and if I miss any, please let me know. We'll start with the margins. Margins were largely driven by favorable customer mix. We also had some improved sourcing on some larger programs that we're able to deliver, and the overall resulted in really strong gross margins, which ultimately dropped into our EBITDA margins. You mentioned pipeline. Pipeline is strong across the board, both with existing customers and new customers.

We mentioned in the past couple of quarters that pipeline has continued to be really strong. We've seen some of that pipeline start to convert into programs that we've won that are delivering revenue both now and are going to continue to roll out into the rest of ’26 and even into ’27. So even though — something we've mentioned before — decision-making is slower on RFPs, a big pipeline results in wins even with slower RFP decisions. So the pipeline continues to be strong.

Even when we win programs or programs fall out of the pipeline, we're replenishing them with new opportunities, which has been really great. And yeah, you're right. On the current quarter, much of the growth has been volume-driven from existing customers — expanding current programs and increasing volumes with existing clients — which has been great. And then we're layering in some of those wins. So we're excited about where things stand. We have a really strong pipeline coming into the back half of the year.

Seeing those results is really exciting for us, and we're looking forward to the rest of the year.

Michael Kopinski, Analyst at Noble Capital Markets

Great. Thanks, guys. Congratulations.

Jake Himelstein (President of Branded Products segment)

Thank you.

OPERATOR (Operator)

The next question comes from Keegan Cox with DA Davidson. Please go ahead.

Keegan Cox, Analyst at DA Davidson

Good morning. Thanks for the question. You’ve delivered a nice 2Q beat. I was just wondering if you can walk through any of the assumptions embedded in your guidance. What leads you to keep the guidance unchanged despite a solid beat on the top line and on EPS?

Mike Koempel, President and CFO

Sure. The guidance — we're reflecting, obviously on the upper end of guidance, Keegan — we're reflecting again the back-half-weighted growth. And that would really be based on the fact that our Healthcare business has become a little bit more cyclical, heavier in the third quarter. So it just reflects the fact that we've had typically a larger second half in Healthcare. And then also I mentioned in Michael's questioning that we expect sequential improvement in the Contact Center business, which again would drive incremental growth in the back half.

I think we also recognize, again touching on a prior question, that we are going through a transition in the Healthcare business. And so you see some margin pressure here in the second quarter. We expect some margin pressure in the back half of the year to some extent. That will depend obviously on the demand in the market as we make changes in our assortment. So I think the guidance reflects the fact that there could be some variability associated with that transition as Chris is making changes in the business.

And so we felt halfway into the year with still a lot of business to go, that it was just appropriate to hold guidance. We're still obviously very optimistic about the business and we'll certainly relook at guidance as we get through the third quarter.

Keegan Cox, Analyst at DA Davidson

Got it. And then a follow-up for me is on Branded Products. I know we've kind of talked about some competitor weakness there before. Does it make sense to make an acquisition there now given that the business is kind of growing in that healthy mid single-digit growth range? Are you still gaining share in the space organically — that’s kind of the real question?

Jake Himelstein (President of Branded Products segment)

Yeah, Keegan, we're gaining share organically and we'll continue to do that. Whether we make an acquisition or not, we're going to aggressively pursue organic growth — both winning new clients and growing existing clients. That said, we're always on the hunt for acquisitions, and if a good one shows up, lands on our doorstep, we're certainly open to doing it. As Michael likes to say, we have to kiss a lot of frogs to find the right company. But we are constantly in conversation with our competition trying to find the next great target.

And if we do, we'll certainly look at it.

Michael Benstock, CEO

I'll add some color to that, Keegan. I'll add some color to that. Mostly what we're looking for are businesses that help expand our ability to service customers — things we're not doing for customers. And there's a lot of areas in the promotional side of our business that we're not doing. It's not our skill set without buying a company, or it would take too long to grow it ourselves. And it could be a channel that we're not in. It could be a customer base or geography that we're not in.

It would be related, of course, to Branded Merchandise in particular. Another area we'd be very interested in is digital. I don't think we have much of an appetite to buy your run-of-the-mill promotional company that basically is selling out of a catalog somewhere and just has a couple of good customers. That's not really what we're looking for. We're looking for something that's very additive to our business. And so, as Jason just reminded you, we kiss a lot of frogs because a lot of people purport to be able to do a lot more than just the run-of-the-mill type of work that promotional merchandise companies usually do, and then when we get under the covers, we find out they're very, very normal and there's nothing special about them. So it'll take time.

Jake Himelstein (President of Branded Products segment)

And Keegan, by way of example, if you look back a little over four years ago — five years ago almost — we acquired a company called Guardian Products. That was an area where we were not in. It was promotional products and Branded Merchandise for auto dealerships. It's tangential; it's related to what we're doing. We were not in that market. We acquired our way into that market and have now grown it substantially since we acquired it, organically.

That's the exact type of acquisition that's really beneficial for us. It's in our space, but not something that we're currently doing, and it provides a great blueprint or roadmap for what we want to do in the future.

Keegan Cox, Analyst at DA Davidson

Got it. And then one more if I can. We've talked about the dynamic of hospitals and other institutional customers carrying leaner inventories. As we look at this Healthcare apparel transformation, is there any impact — how are inventory replenishment trends evolving? Is there any risk to missing out on that trend as you focus that assortment?

Michael Benstock, CEO

No, Michael, not really. I believe that in the past we've spoken about the institutional side conserving cash, and with all the uncertainty around them and not knowing what the reimbursements were going to be from the government and everything else, I think most of that's behind them now. Their business has become very normalized, and we're starting to see that rev up a little bit to a more normal situation. I think the bigger impact, the one that truth has to, is on the consumer.

With consumers paying what they're paying for food and gas and rent and everything else that's gone through the stratosphere, I think a lot of the caregiver community doesn't have as much to spend as they might have a couple of years ago, and so they're being prudent. The good news with respect to that is our consumer product area, which is basically the Wink and the Carhartt scrubs that we sell, has a good, better, best — and even a value — channel for that.

So if they're looking to spend less, they can go from best down to better, or better down to good. We can service them at all levels. And if they're already loyal to our brands, it makes it that much easier for them to make the transition since their awareness is so high. Keegan, you there?

Keegan Cox, Analyst at DA Davidson

Yeah. Great, thank you. That does it for my question.

Michael Benstock, CEO

Sure. Okay.

OPERATOR (Operator)

Our next question comes from Jim Sidoti with Sidoti & Company. Please go ahead.

Jim Sidoti, Analyst at Sidoti & Company

Hi, good morning. Thanks for taking the question. So, Branded Products — this is a third strong quarter. What do you hear from your customers there? Are you starting to get the sense that they're a little bit more confident in the economy and what's going on, or just overall, what's the customer sentiment?

Jake Himelstein (President of Branded Products segment)

Jim, this is Jake. I think the tariff situation becoming a little bit more normalized has certainly helped. We had a couple quarters last year where there was a lot of uncertainty around tariffs, and that created client uncertainty, which created buying uncertainty. That has helped us, certainly. Additionally, us just pushing for more business within our existing clients — to grow who we're working with — helps. Remember, if we work with the HR department, well, if we push into Marketing, we push into HR, we push into Legal, that helps us.

Every department in a large company is buying Branded Merchandise, whether it's uniforms or promotional products or gifting. So a lot of it is improved customer sentiment, but a good part of it's also just us expanding share of wallet within existing customers, which — a lot of times we tell our sales team that our best customer is a current customer — because there is a lot of potential at our existing customers to continue to grow.

Jim Sidoti, Analyst at Sidoti & Company

And on the Contact Centers business, this is the second quarter with sequential improvement. Do you think that trend continues throughout the year? Do you think you hit the low watermark at the end of last year, and you expect that business to continue to grow every quarter?

Mike Koempel, President and CFO

We do expect, Jim, for it to continue. And as I mentioned earlier, our guidance reflects the continued sequential improvement in contact centers. So I'd say we're, you know, we're, like I said, when we started the year, we expected Q1 to be better than Q4, Q2 better than Q1, and it's working out that way. And we're seeing some improvement in conversion and just growth within existing customers. So we're optimistic. And again, the team has done a great job staying focused on managing expenses with that growth.

And we talked about before, we're leveraging technologies internally to not only improve the customer experience through various AI solutions, but we're also leveraging it to create more efficiencies, which again, is helping to keep expenses in check and drop incremental growth to EBITDA.

Jim Sidoti, Analyst at Sidoti & Company

And then last one for me, you know, even with the $2.6 million write-down for healthcare apparel inventory, inventory's down at a little over $90 million, has been down this low in at least six or seven quarters. You know what's going on there? Is that a trend that continues?

Mike Koempel, President and CFO

There's still opportunity, Jim, in our view, to create more efficiency in the healthcare inventories. So we're still focused on bringing those inventories down overall. With that said, as you might imagine, there's pockets of inventory that we're also chasing. So not all inventory is created equal. And I think that we see overall the opportunity to bring inventory down, but we also want to be very thoughtful around not reducing too much and negatively impacting sales.

So there'll be some decreases in, again, certain categories and we'll continue to make investments in others based on demand. But again, overall, we see that being a continued, I'll say, source of cash to us as we look at our cash flow projection going forward.

Jim Sidoti, Analyst at Sidoti & Company

All right, well, thank you. Thanks again for taking the questions.

Michael Benstock, CEO

Thanks, Jim.

OPERATOR (Operator)

Our next question comes from Frank DiLorenzo with Singular Research. Please go ahead.

Frank DiLorenzo, Analyst at Singular Research

Hi. Thanks for taking my call. Just to follow up to M&A opportunities, can we expect any new acquisitions or even partnerships for the balance of this year? Thank you.

Michael Benstock, CEO

I'll answer that, Frank. As we've said, we have a certain level of urgency in our contact center business. And either we will have an acquisition done this year or we will find ourselves doing a startup of a call center in the Philippines that will begin this year and begin to provide revenue next year. Other than that, I would say at this point of the year, there would probably be no other, no other acquisitions other than one in the call center business that might happen.

Frank DiLorenzo, Analyst at Singular Research

Okay, thanks. Also, maybe not directly related to the business, but the cyclospora outbreak. Could you talk about that a little bit? Has it had any impact whatsoever on any of your businesses? Thank you. Okay. Thank you.

Michael Benstock, CEO

Okay, that wraps up the questions, Bailey.

OPERATOR (Operator)

All right. This concludes our question and answer session. I would like to turn the conference back over to Michael Benstock for any closing remarks.

Michael Benstock, CEO

Thank you all. Thanks, Operator. We appreciate you joining us today. We always appreciate your interest in Superior Gr of Cos and look forward to updating you as we move through the back half of the year. As always, please don't hesitate to reach out with any additional questions. And we look forward again to seeing many of you at upcoming conferences. Thanks again.

OPERATOR (Operator)

The conference is now concluded. Thank you for attending today's presentation. You may now disconnect.

Disclaimer: This transcript is provided for informational purposes only. While we strive for accuracy, there may be errors or omissions in this automated transcription. For official company statements and financial information, please refer to the company's SEC filings and official press releases. Corporate participants' and analysts' statements reflect their views as of the date of this call and are subject to change without notice.